Identification of Substituted Naphthotriazolediones as Novel Tryptophan 2,3-Dioxygenase (TDO) Inhibitors through Structure-Based Virtual Screening

被引:51
作者
Wu, Jian-Sung [1 ]
Lin, Shu-Yu [1 ]
Liao, Fang-Yu [1 ]
Hsiao, Wen-Chi [1 ]
Lee, Lung-Chun [1 ]
Peng, Yi-Hui [1 ]
Hsieh, Chia-Ling [1 ]
Wu, Mine-Hsine [1 ]
Song, Jen-Shin [1 ]
Yueh, Andrew [1 ]
Chen, Chun-Hwa [1 ]
Yeh, Shiu-Hwa [1 ]
Liu, Chia-Yeh [2 ]
Lin, Shu-Yi [2 ]
Yeh, Teng-Kuang [1 ]
Hsu, John T. -A. [1 ]
Shih, Chuan [1 ]
Ueng, Shau-Hua [1 ]
Hung, Ming-Shiu [1 ]
Wu, Su-Ying [1 ]
机构
[1] Natl Hlth Res Inst, Inst Biotechnol & Pharmaceut Res, Zhunan Town 350, Miaoli County, Taiwan
[2] Natl Hlth Res Inst, Inst Biomed Engn & Nanomed, Zhunan Town 350, Miaoli County, Taiwan
关键词
GROWTH-FACTOR RECEPTOR; PROTEIN-TYROSINE PHOSPHATASES; INDOLEAMINE 2,3-DIOXYGENASE; CRYSTAL-STRUCTURE; 3-DIMENSIONAL STRUCTURES; SUBSTRATE RECOGNITION; CATALYTIC MECHANISM; DISCOVERY; ASSAY; LIGAND;
D O I
10.1021/acs.jmedchem.5b00921
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A structure-based virtual screening strategy, comprising homology modeling, ligand support binding site optimization, virtual screening, and structure clustering analysis, was developed and used to identify novel tryptophan 2,3-dioxygenase (TDO) inhibitors. Compound 1 (IC50 = 711 nM), selected by virtual screening, showed inhibitory activity toward TDO and was subjected to structural modifications and molecular docking studies. This resulted in the identification of a potent TDO selective inhibitor (11e, IC50 = 30 nM), making it a potential compound for further investigation as a cancer therapeutic and other TDO-related targeted therapy.
引用
收藏
页码:7807 / 7819
页数:13
相关论文
共 55 条
[1]  
[Anonymous], J MOL BIOL
[2]  
[Anonymous], SYBYL X VERS 1 2
[3]   New Substructure Filters for Removal of Pan Assay Interference Compounds (PAINS) from Screening Libraries and for Their Exclusion in Bioassays [J].
Baell, Jonathan B. ;
Holloway, Georgina A. .
JOURNAL OF MEDICINAL CHEMISTRY, 2010, 53 (07) :2719-2740
[4]   A kinetic, spectroscopic, and redox study of human tryptophan 2,3-dioxygenase [J].
Basran, Jaswir ;
Rafice, Sara A. ;
Chauhan, Nishma ;
Efimov, Igor ;
Cheesman, Myles R. ;
Ghamsari, Lila ;
Raven, Emma Lloyd .
BIOCHEMISTRY, 2008, 47 (16) :4752-4760
[5]   Activation of ErbB2 by 2-methyl-1,4-naphthoquinone (menadione) in human keratinocytes: Role of EGFR and protein tyrosine phosphatases [J].
Beier, JI ;
von Montfort, C ;
Sies, H ;
Klotz, LO .
FEBS LETTERS, 2006, 580 (07) :1859-1864
[6]   Energy converting NADH:Quinone oxidoreductase (Complex I) [J].
Brandt, Ulrich .
ANNUAL REVIEW OF BIOCHEMISTRY, 2006, 75 :69-92
[7]   Discovery of positive allosteric modulators and silent allosteric modulators of the μ-opioid receptor [J].
Burford, Neil T. ;
Clark, Mary J. ;
Wehrman, Tom S. ;
Gerritz, Samuel W. ;
Banks, Martyn ;
O'Connell, Jonathan ;
Traynor, John R. ;
Alt, Andrew .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2013, 110 (26) :10830-10835
[8]   Discovery of novel chemotypes to a G-protein-coupled receptor through ligand-steered homology modeling and structure-based virtual screening [J].
Cavasotto, Claudio N. ;
Orry, Andrew J. W. ;
Murgolo, Nicholas J. ;
Czarniecki, Michael F. ;
Kocsi, Sue Ann ;
Hawes, Brian E. ;
O'Neill, Kim A. ;
Hine, Heather ;
Burton, Marybeth S. ;
Voigt, Johannes H. ;
Abagyan, Ruben A. ;
Bayne, Marvin L. ;
Monsma, Frederick J., Jr. .
JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (03) :581-588
[9]   Homology modeling in drug discovery: current trends and applications [J].
Cavasotto, Claudio N. ;
Phatak, Sharangdhar S. .
DRUG DISCOVERY TODAY, 2009, 14 (13-14) :676-683
[10]   Discovery and structure-activity relationships of phenyl benzenesulfonylhydrazides as novel indoleamine 2,3-dioxygenase inhibitors [J].
Cheng, Ming-Fu ;
Hung, Ming-Shiu ;
Song, Jen-Shin ;
Lin, Shu-Yu ;
Liao, Fang-Yu ;
Wu, Mine-Hsine ;
Hsiao, Wenchi ;
Hsieh, Chia-Ling ;
Wu, Jian-Sung ;
Chao, Yu-Sheng ;
Shih, Chuan ;
Wu, Su-Ying ;
Ueng, Shau-Hua .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2014, 24 (15) :3403-3406